gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · KMTSHealthcareSurgical Instruments

Kestra Medical Technologies, Ltd. Common Stock (KMTS)

$30.50+5.14%
Close Nov 4, 2026 · split-adjusted
Oct 30, 2026$29.69▲ 13.13% in range
Nov 3, 2025Low $17.87 · High $30.61Oct 30, 2026
What changed · written from our data
As of Nov 4, 2026

Kestra Medical Technologies closed at $30.50 on Nov 4, up 5.14%, 0.4% below its 52-week closing high. Volume of 1.9M shares was 4.42× its 20-day average (well above normal).

Split-adjusted performance: +12.5% over one month, +47.3% over six months, +16.2% over one year.

In the quarter ended Jul 31, 2026, revenue was $30.97M, up 59.9% from a year earlier, with a net margin of -142.3%.

Short interest was 3.4M shares at the Oct 15 settlement, up 4.6% from the prior report (12.9% of float, 12.3 days to cover).

Market cap$1.82B59.6M shares
Revenue · quarter$31.0M+59.9% YoY
Diluted EPS$-0.75—
P/E · TTM—P/S 17.0×
Net margin-142.3%Gross 56.5%
Dividend yieldNone
52-week range17.87 – 30.61−0.4% from high
Volume1.9M4.42× 20-day avg
Volatility · 60d53.3%Annualised
Short % of float12.9%12.3 days to cover
Net cash$126.4MCash $198.9M
Next earnings—Not scheduled
Split-adjusted performance
1W +2.1%1M +12.5%3M +20.7%6M +47.3%YTD +15.0%1Y +16.2%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum84
Revenue growth95
Net margin20
Value (low P/E)—
Size76

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short3.4M+4.6% vs prior
Days to cover12.3Settled Oct 15
% of float12.9%
Short vol. 10d76.1%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
KMTSKestra Medical Technologies$30.50+5.14%+47.3%+59.9%−142.3%—$1.82B
INSPInspire Medical Systems$66.61+7.61%+45.8%−7.9%−11.8%19.1$1.93BCompare
NVCRNovoCure Limited$14.61+8.79%−11.4%+15.7%−5.4%—$1.71BCompare
LMATLeMaitre Vascular$87.92+9.08%−20.2%+9.6%24.2%30.6$2.01BCompare
TNDMTandem Diabetes Care$19.05+7.93%+5.7%+5.8%−8.3%—$1.33BCompare
UFPTUFP Technologies$329.82+17.66%+51.2%+15.1%12.0%35.3$2.55BCompare
AORTArtivion$26.45+11.56%−23.8%+11.3%−10.7%—$1.29BCompare
ATECAlphatec Holdings$8.28+10.84%+18.5%+12.6%−2.5%—$1.27BCompare
PRCTPROCEPT BioRobotics$21.66+7.39%−12.7%+19.3%−28.4%—$1.24BCompare

News about Kestra Medical Technologies

All news →
Kestra Medical Technologies to Participate in Upcoming Investor ConferencesGlobeNewswire Inc. · 5d ago▲ PositiveKestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research · Sep 14, 2026▼ NegativeKestra Names Daniel Finney Vice President of Research & DevelopmentGlobeNewswire Inc. · Sep 10, 2026▲ PositiveKestra Appoints Curtis Kopf as Senior Vice President of Customer ExperienceGlobeNewswire Inc. · Aug 26, 2026▲ PositiveKestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”GlobeNewswire Inc. · Mar 25, 2026▲ Positive

Quick answers

What does Kestra Medical Technologies do?
Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery.
What is KMTS's market cap?
$1.82B, based on the Nov 4 close of $30.50.
Does Kestra Medical Technologies pay a dividend?
No regular cash dividend has been paid in the last year.
How much of KMTS is sold short?
3.4M shares, 12.9% of float, as of Oct 15, 2026.
What sector is KMTS in?
Healthcare, in the Surgical Instruments industry.

About Kestra Medical Technologies

Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.

HQ: Kirkland, WA443 employeesListed Mar 6, 2025kestramedical.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology